Back to top Open menu arrow
Download PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Letter to the Editor July 15, 2003

Olanzapine/Risperidone and Diabetes Risk

;

J Clin Psychiatry 2003;64(7):847-848

Article Abstract

Letter to the Editor

Olanzapine/Risperidone and Diabetes Risk.

Also from JCP

Catching Cognitive Decline Early with Gary W. Small, MD Proton Pump Inhibitors and the Risk of Dementia Digital Cognitive Intervention in Older People at Risk of Dementia

From the Editors

Episode 17 The JCP Podcast Up to 80% of patients with serious mental illness may not take medication as prescribed, so what looks like treatment failure can actually be pseudoresistance. This conversation makes a sharp case for treating deprescribing with the same planning, monitoring, and shared decision-making as prescribing in the first place.

 

About the Authors

This PDF is free for all visitors!

The Journal of Clinical Psychiatry June 2026 cover with featured article titles

Vol 87 • 2026 • Number 2

Read the Current Issue

Original Research

CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial

Original Research

Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease

Systematic Review

Thirty Years of the Diagnostic Criteria for Psychosomatic Research

Original Research

Efficacy of Olanzapine/Samidorphan on Negative Symptoms

Original Research

Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits

Clinical and Practical Psychopharmacology

Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes
View current Issue

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe